Toxic environment and obesity pandemia: Is there a relationship?

Italian Journal of Pediatrics

Volumn 36, Issue 8, 2010, Pages

  Latini, Giuseppe ^a,b   Gallo, Francesco ^a   Iughetti, Lorenzo ^c  

^a PERRINO HOSPITAL   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 4,4' ISOPROPYLIDENEDIPHENOL; CYTOCHROME P450; ENDOCRINE DISRUPTOR; PESTICIDE; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL;

ADIPOSE TISSUE; ENERGY BALANCE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE EXPRESSION PROFILING; HEALTH HAZARD; HUMAN; LIFESTYLE; NOTE; OBESITY; PANDEMIC; POLLUTANT; QUALITY OF LIFE; RISK ASSESSMENT; SITTING; FEMALE; HEALTH; MALE; MORBIDITY; REVIEW; RISK FACTOR;

ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MORBIDITY; OBESITY; RISK FACTORS; WORLD HEALTH;

EID: 77649217396     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-36-8     Document Type: Note

References (40)

1. Kipping RR, Jago R, Lawlor DA: Obesity in children. Part 1: Epidemiology, measurement, risk factors, and screening. BMJ 2008, 337:a1824.
2. James WP: The epidemiology of obesity: the size of the problem. J Intern Med 2008, 263:336-52.
3. Ford ES, Mokdad AH: Epidemiology of obesity in the Western Hemisphere. J Clin Endocrinol Metab 2008, 93(11 Suppl 1):S1-8.
4. Shaw J: Epidemiology of childhood type 2 diabetes and obesity. Pediatr Diabetes 2007, 8(Suppl 9):7-15.
5. Caprio S: Insulin resistance in childhood obesity. Pediatr Endocrinol Metab 2002, 15(Suppl 1):487-92.
6. Grün F: Blumberg B. Endocrine disrupters as obesogens. Mol Cell Endocrinol 2009, 304:19-29.
7. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN: Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 2007, 51:912-7.
8. Heindel JJ, vom Saal FS: Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 2009, 304:90-6.
9. Schell LM, Gallo MV, Ravenscroft J: Environmental influences on human growth and development: Historical review and case study of contemporary influences. Ann Hum Biol 2009, 36:459-477.
10. Foster WG, Agzarian J: Toward less confusing terminology in endocrine disruptor research. J Toxicol Environ Health B Crit Rev 2008, 11:152-61.
11. Tabb MM, Blumberg B: New modes of action for endocrine-disrupting chemicals. Mol Endocrinol 2006, 20:475-82.
12. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ: Effects of endocrine disruptors on obesity. Int J Androl 2008, 31:201-8.
13. Newbold RR, Padilla-Banks E, Jefferson WN: Environmental estrogens and obesity. Mol Cell Endocrinol 2009, 304:84-9.
14. Yoshinari K, Sato T, Okino N, Sugatani J, Miwa M: Expression and induction of cytochromes p450 in rat white adipose tissue. J Pharmacol Exp Ther 2004, 311:147-54.
15. Heindel JJ, vom Saal FS: Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 2009, 304:90-6.
16. Elobeid MA, Allison DB: Putative environmental-endocrine disruptors and obesity: a review. Curr Opin Endocrinol Diabetes Obes 2008, 15:403-8.
17. Merrill M, Baston DS, Denison MS, Birnbaum LS, Pomp D, Threadgill DW: Mouse breast cancer model-dependent changes in metabolic syndromeassociated phenotypes caused by maternal dioxin exposure and dietary fat. Am J Physiol Endocrinol Metab 2009, 296:E203-10.
18. Gluckman PD, Lillycrop KA, Vickers MH, Pleasants AB, Phillips ES, Beedle AS, Burdge GC, Hanson MA: Metabolic plasticity during mammalian development is directionally dependent on early nutritional status. Proc Natl Acad Sci USA 2007, 104:12796-800.
19. Hanson MA, Gluckman PD: Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol 2008, 102:90-3.
20. Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006, 6:772-783.
21. Margetic S, Gazzola C, Pegg GG, Hill RA: Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002, 26:1407-33.
22. Sperling MA: Disorders of energy balance. Pediatric endocrinology textbook , 3 2008, 788-796.
23. Díez JJ, Iglesias P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148:293-300.
24. Rondinone CM: Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006, 29:81-90.
25. Shah A, Mehta N, Reilly MP: Adipose inflammation, insulin resistance, and cardiovascular disease. J Parenter Enteral Nutr 2008, 32:638-644.
26. Ghosh D, Griswold J, Erman M, Pangborn : Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 2009, 457:219-23.
27. Siviero-Miachon AA, Spinola-Castro AM, Guerra-Junior G: Adiposity in childhood cancer survivors: insights into obesity physiopathology. Arq Bras Endocrinol Metab 2009, 53:190-200.
28. Prokesch A, Hackl H, Hakim-Weber R, Bornstein SR, Trajanoski Z: Novel insights into adipogenesis from omics data. Curr Med Chem 2009, 16:2952-64.
29. Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, Hashimoto N, Mori C: Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 2004, 141:209-14.
30. Iyawaki J, Sakayama K, Kato H, Yamamoto H, Masuno H: Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb 2007, 14:245-52.
31. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N: Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008, 116:1642-7.
32. Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, Webster TF: Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 2008, 3:7-27.
33. Desvergne B, Feige JN, Casals-Casas C: PPAR-mediated activity of phthalates: A link to the obesity epidemic?. Mol Cell Endocrinol 2009, 304:43-8.
34. Inadera H, Shimomura A: Environmental chemical tributyltin augments adipocyte differentiation. Toxicol Lett 2005, 159:226-34.
35. Karmaus W, Osuch JR, Eneli I, Mudd LM, Zhang J, Mikucki D, Haan P, Davis S: Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occup Environ Med 2009, 66:143-9.
36. Latini G, Wittassek M, Del Vecchio A, Presta G, De Felice C, Angerer J: Lactational Exposure to Phthalates in Southern Italy. Environ Int 2009, 35:236-239.
37. Phrakonkham P, Viengchareun S, Belloir C, Lombès M, Artur Y, Canivenc-Lavier MC: Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J Steroid Biochem Mol Biol 2008, 110:95-103.
38. Sargis RM, Johnson DN, Choudhury RA, Brady MJ: Environmental Endocrine Disruptors Promote Adipogenesis in the 3T3-L1 Cell Line through Glucocorticoid Receptor Activation. Obesity (Silver Spring) 2009.
39. Kern PA, Fishman RB, Song W, Brown AD, Fonseca V: The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on oxidative enzymes in adypocites and liver. Toxicology 2002, 171:117-25.
40. Cranmer M, Louie S, Kennedy RH, Kern PA, Fonseca VA: Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol Sci 2000, 56:431-6.